The company has too many irons in the fire for the price to be this low. They have several milestones coming thru out 2016 and into 2017 and the cash to get there. The move up to 1.40 was very fast, but it will get there again soon. If they hit on any of their goals the stock will more than double from here.
I get the MTSL letter and it has been one of their picks for quite some time. Concerning future news, the inside people always know before us and there may be a positive surprise coming. Or, it could be just the day traders playing games. I'm sitting on a big loss at the current price and feel the risk to reward is very favorable.
With all the milestones coming up in the next year and the cash to get there, OGXI should be trading at $2 - $3 right now just on potential. If the bio tech stocks were not hated so much right now the price would be a lot higher.
20% move up since the ER. IMO the move up will continue with increasing volume. OGXI has 3 major events before end of 2016 any of which could create a big move up in the stock price.
MTSL likes ZIOP and that is good enough for me. We can only hope this falls to $6 today so as to add on the weakness. Adam F. put out a hit against XON last week and it made a very nice recovery. I expect that ZIOP will do the same. You can never convince me that Adam is not trying to provide cover for the shorts on these stocks.
This stock was trashed along with all the other bio tech. As have said in the past OGXI should be trading between $2 to $3 at a minimium based on potential alone.
Read last ER, they have 4 or 5 phase 2 and 3 trials on going and will report results in 2016 / 2017. Cash is sufficient to wait out all the results. If any of these trials hit, OGXI will increase 2x to 5x in price. The risk to reward seems to be very good.
The drop to 1.07 (and bounce back) today should surprise no one after the 20% move up in less than a week. Higher prices will continue going forward.
Or it could go up big on ANY of their 6 on going trials. Is the glass half empty or almost full? At worst the OGXI would only have to pay a percentage of the $23 million and this would not be a "show stopper" to their programs. Wonder if you are short this stock.....there is always high risk in bio tech, but in this case, the risk to reward much favors the reward side I think.
If OGXI can close today and Monday at or above the min bid of $1, that will meet the NAZ requirement of 10 business days. The de-listing issue will be removed (NAZ will notify in 3 business days - might be a pop in price). Must say I'm surprised by the move up today with the market conditions.